AstraZeneca Loses C.F.O. to Goldman Sachs
634339
The move comes just months after Jon Symonds completed the $15.2 billion purchase of MedImmune, which some investors considered too expensive.
691286
Drug maker AstraZeneca PLC said Friday that the Food and Drug Administration did not approve its orally taken blood thinner Exanta.
426995
AstraZeneca Plc suffered its third  setback in two months on Friday as lung cancer drug Iressa  failed to help patients live longer in a major clinical trial,  sending its shares down more than 8 percent.
268759
The larger pharmaceutical drops out of daclizumab development.
300628
US District Judge Patti B. Saris ruled against pharmaceutical companies AstraZeneca PLC , Schering-Plough Corp. , and Bristol-Myers Squibb Co. in Boston yesterday, finding them guilty of engaging in unfair and deceptive trade practices for their medication prices, according to the law firm of Hagens Berman Sobol Shapiro LLP.
697777
Business & money: Blow for RBS-led consortium as Dutch court rules ABN Amro acted lawfully when it agreed to sell LaSalle to Bank of America without shareholder approval.
579429
Novartis AG, Switzerland s largest drugmaker, withdrew an application for European Union approval of its experimental Prexige, a painkiller similar to Merck & Co.
647520
The companies have lost a court ruling that may result in their paying royalties on an experimental cancer drug to an Israeli research institute.
410890
AstraZeneca shares have fallen more than 6 percent after a US medical panel recommended regulators reject its anti-clotting pill Exanta, a key product for the company&#39;s future growth.
735577
Shares in OSI Pharmaceuticals (OSIP :Nasdaq - news - research) and Genentech (DNA :Nasdaq - news - research) jumped Friday after AstraZeneca (AZN :NYSE - news - research) said new medical data showed its lung cancer drug Iressa provided no survival
292172
Merck &amp; Co., the second-largest US drugmaker, lost its AAA credit rating from Standard &amp; Poor&#39;s because of revenue losses and potential liabilities from the company&#39;s September recall of the Vioxx painkiller.
488041
Foreign drug stocks were in the spotlight Thursday with Food and Drug Administration news pulling the sector down. AstraZeneca PLC took a drubbing on the eve of its FDA advisory panel meeting for its orally
226836
AstraZeneca Plc suffered its third setback in two months on Friday as lung cancer drug Iressa failed to help patients live longer
224503
Shionogi Co. shares fell as much as 14.4 percent in Tokyo on concerns in the European Union and US about the safety of Crestor, a cholesterol-reducing drug developed by the Japanese company and sold by AstraZeneca Plc.
425955
DRUGS group AstraZeneca today suffered a massive setback after tests showed its blockbuster Iressa cancer treatment did not allow patients to live longer.
569835
The F.D.A. said that it would consider whether to remove Iressa, a product from AstraZeneca, from the market after the drug failed to prolong the lives of people in a clinical trial.
77441
AstraZeneca, Bristol-Myers Squibb and Schering-Plough must pay damages for overcharging on certain drugs.